Varsetatug masetecan

玛康沃塞妥塔单抗

Report date: 2026/04/17 20:02:02

Base Information

Drug NameVarsetatug masetecan
Drug Alias NameEpCAM PROBODYCX-2051Varseta-M
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Camptothecin derivative payload
Mechanisms of ActionAnti-EpCAMDNA topoisomerase I inhibitors
TargetsEpithelial cell adhesion moleculeDNA topoisomerase I
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCytomx Therapeutics IncImmunogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesCytomx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A